Element Biosystems, LLC to acquire Standard BioTools Inc.

Element Biosystems, LLC has agreed to acquire Standard BioTools Inc. in a cash asset sale. The transaction was announced on 30 September 2026 and is valued at five million five hundred thousand US dollars. Both the buyer and the target are based in the United States. The deal falls within the healthcare sector. The consideration is entirely cash, with no equity component reported. The current status of the transaction is firm intention, indicating that the parties have reached a definitive agreement. No completion date has been reported, and the deal remains pending finalisation. This acquisition represents a strategic move for Element Biosystems to expand its portfolio within the healthcare industry. The specific assets being transferred are not detailed in the available data. The headline offer reflects the total value of the transaction as reported. Regulatory approvals may still be required before the deal can close. The parties have committed to completing the transfer of assets according to the agreed terms. This summary is based solely on the provided facts regarding the deal structure, value, and status.